Can We Reliably Needle Hip Muscles Blindly?
Launched by ERZURUM REGIONAL TRAINING & RESEARCH HOSPITAL · Jul 18, 2025
Trial Information
Current as of July 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how accurately doctors can place needles into specific muscles around the hip without using imaging tools to guide them. The study focuses on common hip muscles that are often targeted during treatments like dry needling or injections for pain relief. Doctors will perform these needle placements “blindly” (without seeing inside the body), and then use ultrasound, a safe imaging method, to check if the needle actually reached the right spot. This research aims to see how often these procedures hit their intended targets, which could help improve training for healthcare providers and make treatments safer and more effective in the future.
Adults aged 18 to 65 who have ongoing pain in the hip, groin, or front thigh area and are scheduled for physical therapy may be eligible to participate, especially if their pain might be related to muscle problems in the hip region. Participants should be able to cooperate with the procedure and give written consent. People who take blood thinners, have serious hip problems, infections, or other serious health issues, or who are pregnant, would not be able to join. During the study, participants will undergo needle placements in five different hip muscles, with careful monitoring for 24 hours afterward to watch for any discomfort or complications. It’s important to note that this study is not designed to treat pain but to understand how precise these needle procedures are when done without imaging help.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults aged 18 to 65 years
- • Individuals with nonspecific hip, groin, or anterior thigh pain who are scheduled for physical therapy
- • Clinical suspicion of myofascial pain syndrome, particularly involving muscles around the hip
- • Patients with clinical indication for dry needling or similar invasive treatments (e.g., targeting muscles such as iliacus, pectineus, sartorius)
- • Ability to cooperate with the procedure
- • Ability to provide written informed consent
- Exclusion Criteria:
- • Use of anticoagulant medications (due to increased risk of bleeding)
- • Severe hip osteoarthritis, presence of hip prosthesis, history of previous hip surgery, or significant anatomical deformity
- • Active infection or skin lesion at the planned injection site
- • Inability to cooperate or communicate effectively
- • Pregnancy
- • Presence of serious systemic illnesses (e.g., malignancy, neurological disorders)
About Erzurum Regional Training & Research Hospital
Erzurum Regional Training & Research Hospital is a prominent healthcare institution located in Erzurum, Turkey, dedicated to advancing medical research and improving patient care. As a clinical trial sponsor, the hospital leverages its extensive resources and expertise to facilitate innovative research initiatives, focusing on a wide range of medical disciplines. Committed to scientific excellence and ethical standards, Erzurum Regional Training & Research Hospital collaborates with various stakeholders to enhance the understanding of diseases and develop novel therapeutic approaches, ultimately contributing to the betterment of healthcare outcomes in the region and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported